Clinical characteristics such as biochemical and tumor biomarkers also play an important role in HCC diagnosis and prognosis (17–22), with the MTM-HCC being associated with a higher Barcelona Clinical Liver Cancer (BCLC) stage, poor histologic differentiation and higher serum alpha-fetoprotein (AFP) (6, 23). This evidence concerns the gene AFP and hepatocellular carcinoma.